UCI president hopes for breakthrough in Chris Froome case before Giro d'Italia
David Lappartient wants to see case resolved quickly, but emphasises the right of Froome to mount a proper defence
UCI president David Lappartient says that he hopes that the anti-doping investigation into Chris Froome will be concluded - one way or another - before the start of the Giro d'Italia in May.
Froome is currently under investigation after delivering an adverse analytical finding for salbutamol at the 2017 Vuelta a España, and due to the nature of the substance is not subject to a provisional suspension meaning that he could take to the start line of the Giro d'Italia in Jerusalem on May 6 with the investigation still ongoing.
The four-time Tour de France winner has denied breaking anti-doping rules which allow athletes to take a maximum of 800mg of salbutamol per 12 hours and, with Team Sky’s backing, has vowed to clear his name. However for Lappartient the issue is to have the case resolved fairly, and ideally before the Giro d'Italia.
>>> Everything you need to know about Chris Froome's salbutamol case
"I hope so," was the UCI president's response when asked by Swiss newspaper Neue Zürcher Zeitung if the case would be resolved before May 6. "The case is very bad for cycling. He is the most famous rider we have.
"Froome is not a rider like any other. He has more money. He can find more experts who can speak for his case. He can submit more exculpatory documents.
"We cannot simply wipe these statements off the table. It is important to solve the case quickly, but also to protect the rights of the rider."
Get The Leadout Newsletter
The latest race content, interviews, features, reviews and expert buying guides, direct to your inbox!
Watch: Giro d'Italia 2018 route guide
http://www.youtube.com/watch?v=WWVoFpEyh_I
Froome has continued his preparation for the 2018 season as normal despite the ongoing investigation, attending a Team Sky training camp in Mallorca as well as putting in some long training rides in South Africa.
Meanwhile lawyers and medical experts have been working to prepare Froome's defence in the investigation, with reports saying that they will argue that a kidney problem was to blame for Froome being found to have twice the permitted concentration of the asthma drug salbutamol in his system in a urine test taken after stage 17 of the Vuelta a España.
>>> Team Sky 'will implode' if Chris Froome get banned, says Floyd Landis
Lappartient also commented on the reactions of other riders to the Froome case, in particular Tony Martin, who received a "clarification" phone call from the UCI after he accused the sport's governing body of "double standards".
"I recognize the right of riders to express their opinions," Lappartient continued. "They are worried and want a clean sport. It's good.
"But there is no special treatment for Froome. We have explained that to Martin. He's a clever guy and has realised that he may have made a mistake."
Thank you for reading 20 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Henry Robertshaw began his time at Cycling Weekly working with the tech team, writing reviews, buying guides and appearing in videos advising on how to dress for the seasons. He later moved over to the news team, where his work focused on the professional peloton as well as legislation and provision for cycling. He's since moved his career in a new direction, with a role at the Department for Environment, Food and Rural Affairs.
-
Parlee Cycles' Ouray reviewed: a bike that goes zoom but doesn’t fit like a race bike and is made in the USA
The first new model since dealing with bankruptcy, the Ouray is a comfortable, big-tyre road bike from the storied American brand
By Tyler Boucher Published
-
Forget distance covered, these are the key stats to note in your Strava Year in Sport
We asked a coach how to best analyse our end of year Strava data
By Tom Davidson Published
-
Chris Froome misses out on Tour de France selection
39-year-old absent from Israel-Premier Tech's eight-rider roster
By Tom Davidson Published
-
A complete history of Ineos Grenadiers kits, from Adidas to Gobik, via Rapha
The British team switch to Gobik in 2024 after two years with Bioracer
By Tom Thewlis Published
-
Chris Froome's boss rubbishes claims bike fit is behind lack of results
'He can talk about his bike position until the cows come home - that's still not going to earn him a position on a Grand Tour team' says Israel-Premier Tech team owner Sylvan Adams
By Tom Thewlis Published
-
Chris Froome, rim brake evangelist, 'warms to' disc brakes
The Israel-Premier Tech rider, also an investor at Factor Bikes, says that he has "way less problems" with discs these days
By Adam Becket Published
-
Is Chris Froome - in 2023 - a professional cyclist, or an influencer?
The seven-time Grand Tour winner hasn't raced since July, but has taken to being interesting on social media
By Adam Becket Published
-
Chris Froome 'absolutely not' worth multi-million euro salary says his team boss
The four-time Tour de France winner was not selected for this year's Tour de France for performance reasons, Israel-Premier Tech boss Sylvan Adams says
By Chris Marshall-Bell Published
-
Chris Froome not selected for Tour de France 2023
38-year-old misses out on 'ultimate goal' as Israel-Premier Tech confirm eight-man squad
By Tom Davidson Published
-
Back to Africa: Chris Froome on going back to his roots, his future and cycling's new generation
He’s come full circle, but is there time for another loop? We talk to the four-time Tour champ about his and African cycling’s future
By Adam Becket Published